LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Roche Showcases Innovative Laboratory Solutions and Digital Diagnostics

By LabMedica International staff writers
Posted on 21 May 2023
Print article
Image: The cobas 5800 molecular diagnostics system expands access to testing and improves patient care (Photo courtesy of Roche Diagnostics)
Image: The cobas 5800 molecular diagnostics system expands access to testing and improves patient care (Photo courtesy of Roche Diagnostics)

Roche Diagnostics (Basel, Switzerland) is showcasing innovative laboratory solutions and digital diagnostics through - "Innovation Past, Present and Future" at this year's WorldLab-EuroMedLab 2023 in Rome, Italy, 21-25 May. Attendees can experience first-hand Roche's latest technological advancements in lab automation, serum work area, molecular and point of care solutions, and discover how the company is transforming patient care through advancements in breakthrough high-medical value diagnostic and digital solutions.

At the 2023 EuroMedLab Congress, Roche is featuring new innovations, such as several molecular systems from the growing PCR portfolio – the cobas 5800 and the new LightCycler PRO System, which will be launched later this year. A prototype for the new cobas Mass Spec system is being unveiled, bringing mass spectrometry into the routine testing environment. The system complements the serum work area portfolio, allowing healthcare communities to benefit in the future from an extended diagnostic platform offering clinical chemistry, heterogeneous immunoassays, and mass spectrometry.

The new cobas connection modules (CCM Vertical), a flexible modular system that makes effective utilization of lab space and seamlessly integrates into the existing cobas connection modules, improving lab efficiency, is also being featured at the industry event. Roche is also introducing its navify digital solutions to the laboratory community that are designed to fulfill the laboratories' need for seamless and secure connectivity between systems, instruments and even devices from different providers, as well as empowering lab leaders to drive operational efficiencies and help clinicians gain greater medical insights.

"With the ever-changing needs of the healthcare system, laboratories, and clinicians are expected to optimize laboratory operations and efficiencies while improving patient care," said Ann Costello, Head of Roche Diagnostics Solutions at Roche Diagnostics. "We are pleased to present the next generation of innovative solutions that simplify and streamline testing for laboratories of all sizes, throughputs, and disciplines while supporting clinical decision-making to improve patient care."

"Laboratories have a unique opportunity to connect siloed data across systems and points of care for greater insights," said Moritz Hartmann, Head of Roche Information Solutions at Roche Diagnostics. "At Roche, we are working closely together with lab leaders to enable more patient-centered care. Our navify portfolio of integrated digital solutions enables open digital ecosystems that connect to innovations, drive operational efficiencies, and generate actionable insights for improved patient care."

Related Links:
Roche Diagnostics 

Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Respiratory Bacterial Panel
Real Respiratory Bacterial Panel 2
New
Multi-Function Pipetting Platform
apricot PP5

Print article

Channels

Clinical Chemistry

view channel
Image: The tiny clay-based materials can be customized for a range of medical applications (Photo courtesy of Angira Roy and Sam O’Keefe)

‘Brilliantly Luminous’ Nanoscale Chemical Tool to Improve Disease Detection

Thousands of commercially available glowing molecules known as fluorophores are commonly used in medical imaging, disease detection, biomarker tagging, and chemical analysis. They are also integral in... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Microbiology

view channel
Image: The lab-in-tube assay could improve TB diagnoses in rural or resource-limited areas (Photo courtesy of Kenny Lass/Tulane University)

Handheld Device Delivers Low-Cost TB Results in Less Than One Hour

Tuberculosis (TB) remains the deadliest infectious disease globally, affecting an estimated 10 million people annually. In 2021, about 4.2 million TB cases went undiagnosed or unreported, mainly due to... Read more

Technology

view channel
Image: The HIV-1 self-testing chip will be capable of selectively detecting HIV in whole blood samples (Photo courtesy of Shutterstock)

Disposable Microchip Technology Could Selectively Detect HIV in Whole Blood Samples

As of the end of 2023, approximately 40 million people globally were living with HIV, and around 630,000 individuals died from AIDS-related illnesses that same year. Despite a substantial decline in deaths... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Sekisui Diagnostics UK Ltd.